ATE403152T1 - Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe

Info

Publication number
ATE403152T1
ATE403152T1 AT01976048T AT01976048T ATE403152T1 AT E403152 T1 ATE403152 T1 AT E403152T1 AT 01976048 T AT01976048 T AT 01976048T AT 01976048 T AT01976048 T AT 01976048T AT E403152 T1 ATE403152 T1 AT E403152T1
Authority
AT
Austria
Prior art keywords
epitope
protein
parent
sequences
parent protein
Prior art date
Application number
AT01976048T
Other languages
English (en)
Inventor
Michael Lassen
Morten Breindahl
Original Assignee
Besst Test Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besst Test Aps filed Critical Besst Test Aps
Application granted granted Critical
Publication of ATE403152T1 publication Critical patent/ATE403152T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Eye Examination Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01976048T 2000-10-17 2001-10-12 Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe ATE403152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001546 2000-10-17
US24213500P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE403152T1 true ATE403152T1 (de) 2008-08-15

Family

ID=8159792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976048T ATE403152T1 (de) 2000-10-17 2001-10-12 Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe

Country Status (6)

Country Link
EP (2) EP1340085B1 (de)
AT (1) ATE403152T1 (de)
AU (1) AU2002210394A1 (de)
CA (1) CA2425380A1 (de)
DK (1) DK1340085T3 (de)
WO (1) WO2002032947A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9476032B2 (en) 2007-03-30 2016-10-25 The Research Foundation For The State University Of New York Attenuated viruses useful for vaccines
DE102008028295A1 (de) * 2008-06-13 2009-12-17 Engler, Jörg Mittel zur direkten Detektion von Borrelia bugdorferi sensu lato in Arthropoden vor Ort (ohne Labor)
EP3822635A1 (de) 2014-03-07 2021-05-19 The Regents Of The University Of California Vorrichtungen zur integration der extraktion, konzentration und detektion von analyten
AU2016318103B2 (en) 2015-09-04 2022-11-17 The Regents Of The University Of California Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
AU2017277631B2 (en) 2016-06-09 2024-01-25 The Regents Of The University Of California Biomarker concentration and signal amplification for use in paper-based immunoassays and a single platform for extracting, concentrating, and amplifying DNA
WO2018039139A1 (en) 2016-08-22 2018-03-01 The Regents Of The University Of California Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection
US11209427B2 (en) 2017-03-27 2021-12-28 The Regents Of The University Of California Semi-quantitative lateral-flow immunoassay for the detection of CSF leaks
CN116121103B (zh) * 2022-09-16 2024-09-27 中国烟草总公司郑州烟草研究院 一株解淀粉芽孢杆菌及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1062341E (pt) * 1998-03-16 2008-12-24 Alk Abello As Alergénios recombinantes mutantes
DE69916306T2 (de) * 1998-10-30 2005-05-04 Novozymes A/S Niedrigallergene proteinvarianten
US20020009452A1 (en) * 1999-02-10 2002-01-24 Michael Caplan Method for altering undesirable immune responses to polypeptides
AU3717600A (en) * 1999-03-02 2000-09-21 Board Of Trustees Of The University Of Arkansas, The Methods and reagents for decreasing clinical reaction to allergy

Also Published As

Publication number Publication date
WO2002032947A1 (en) 2002-04-25
DK1340085T3 (da) 2008-12-01
AU2002210394A1 (en) 2002-04-29
EP1328544A1 (de) 2003-07-23
EP1340085A1 (de) 2003-09-03
CA2425380A1 (en) 2002-04-25
EP1340085B1 (de) 2008-07-30

Similar Documents

Publication Publication Date Title
WO2000026230A8 (en) Low allergenic protein variants
JP2004504001A (ja) スプライソソーム媒介ｒｎａトランスースプライシングにおける使用のための方法及び組成物
WO2003074676A3 (en) Wax ester synthase dna sequence, protein and uses thereof
DE69829976D1 (de) Verfahren zur trocknung von kompetenten zellen
ATE547528T1 (de) Eine neue gruppe von alpha-amylasen sowie ein verfahren zur identifizierung und gewinnung neuer alpha-amylasen
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
PL415463A1 (pl) Wyizolowany kwas nukleinowy, ssaczy wektor ekspresyjny, fuzje polipeptydowe, komórki gospodarza, sposób wytwarzania fuzji polipeptydowych, sposoby in vitro i ex vivo modyfikowania profilu glikozylacji, wyizolowana cząsteczka kwasu nukleinowego
CA2440592A1 (en) Oxidation-reduction sensitive green fluorescent protein variants
WO2006124644A3 (en) Protein and antibody profiling using small molecule microarrays
ATE393237T1 (de) Mittel und verfahren zur in-vitro-bestimmung von camp
SE9500023L (sv) Sätt att detektera cancer
ATE403152T1 (de) Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe
DE602004028724D1 (de) Verfahren zur herstellung sezernierter polypeptide
ATE320484T1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
ATE498013T1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
DE60333486D1 (de) Fluoreszenzproteine aus copepoda-spezies und verfahren zur verwendung davon
ATE274595T1 (de) Verfahren zum transfer von molekularen substanzen mit prokaryontischen nukleinsaure-bindenden proteinen
DE69838644D1 (de) Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors
WO2001064913A3 (en) Cell cycle proteins associated with rad9, compositions and methods of use
ATE449173T1 (de) 32144, eine humane fettsäureamid-hydrolase und deren verwendungen
WO1998054212A3 (de) Das protein des humanen ryanodinrezeptors vom typ 3 sowie dafür kodierende dna-moleküle
WO2006126068A3 (en) Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia
ATE382089T1 (de) Verfahren zum herstellen eines rekombinanten proteins
WO2001030987A3 (en) Tankyrase h, compositions involved in the cell cycle and methods of use
DE60018605D1 (de) Ing2, ein mit iaps assoziiertes zellzyklusprotein, sowie zusammensetzungen, verfahren und verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties